ORG Wealth Partners
JBIO icon

ORG Wealth Partners’s Jade Biosciences JBIO Stock Holding History

ORG Wealth Partners’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14 Buy
+1
New +$20 ﹤0.01% 2533

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Remedium Capital Partners
Remedium Capital Partners Fort Lauderdale, Florida $274M AUM 288.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Versant Venture Management
Versant Venture Management San Francisco, California $109M AUM 43.78% 1-Year Est. Return

ORG Wealth Partners's JBIO Position: Q3 2026 in Review

ORG Wealth Partners opened a new position in Jade Biosciences (JBIO) in Q3 2026: 1 share worth $14. The stake represents ﹤0.01% of the portfolio and ranks #2533 among its holdings.

102 funds tracked by Wall St. Rank hold JBIO as of Q3 2026.

  • ORG Wealth Partners held 1 share of Jade Biosciences worth $14 as of Q3 2026.
  • Jade Biosciences was a new ORG Wealth Partners position in Q3 2026.
  • Jade Biosciences made up ﹤0.01% of ORG Wealth Partners's portfolio in Q3 2026, its #2533 holding.
  • 102 funds tracked by Wall St. Rank held Jade Biosciences as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.